Switch theme
Sign up to access all valuation multiples
Klea Holding focused on the acquisition, development and digitalization of companies in multiple sectors. Its development of Smart Salem, the first network of digital medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the Emirates United Arabs, or its Smart Health joint venture developed in Saudi Arabia.
2007
123
LTM Revenue $21.2M
LTM EBITDA $4.5M
$62.6M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Klea has a last 12-month revenue (LTM) of $21.2M and a last 12-month EBITDA of $4.5M.
In the most recent fiscal year, Klea achieved revenue of $19.4M and an EBITDA of $4.4M.
Klea expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Klea valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $21.2M | XXX | $19.4M | XXX | XXX | XXX |
| Gross Profit | $21.2M | XXX | $9.3M | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | 48% | XXX | XXX | XXX |
| EBITDA | $4.5M | XXX | $4.4M | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 23% | XXX | XXX | XXX |
| EBIT | $2.5M | XXX | $2.2M | XXX | XXX | XXX |
| EBIT Margin | 12% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $2.0M | XXX | $1.6M | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $2.9M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Klea's stock price is EUR 0 (or $0).
Klea has current market cap of EUR 53.1M (or $59.7M), and EV of EUR 55.7M (or $62.6M).
See Klea trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $62.6M | $59.7M | XXX | XXX | XXX | XXX | $0.00 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Klea has market cap of $59.7M and EV of $62.6M.
Klea's trades at 3.2x EV/Revenue multiple, and 14.3x EV/EBITDA.
Equity research analysts estimate Klea's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Klea has a P/E ratio of 29.3x.
See valuation multiples for Klea and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $59.7M | XXX | $59.7M | XXX | XXX | XXX |
| EV (current) | $62.6M | XXX | $62.6M | XXX | XXX | XXX |
| EV/Revenue | 2.9x | XXX | 3.2x | XXX | XXX | XXX |
| EV/EBITDA | 13.8x | XXX | 14.3x | XXX | XXX | XXX |
| EV/EBIT | 25.4x | XXX | 28.6x | XXX | XXX | XXX |
| EV/Gross Profit | 2.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 29.3x | XXX | 37.8x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 335.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialKlea's last 12 month revenue growth is 19%
Klea's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Klea's rule of 40 is 62% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Klea's rule of X is 69% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Klea and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 19% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Margin | 21% | XXX | 23% | XXX | XXX | XXX |
| EBITDA Growth | 40% | XXX | -7% | XXX | XXX | XXX |
| Rule of 40 | 62% | XXX | 42% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 69% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 37% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Klea acquired XXX companies to date.
Last acquisition by Klea was XXXXXXXX, XXXXX XXXXX XXXXXX . Klea acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Klea founded? | Klea was founded in 2007. |
| Where is Klea headquartered? | Klea is headquartered in France. |
| How many employees does Klea have? | As of today, Klea has 123 employees. |
| Is Klea publicy listed? | Yes, Klea is a public company listed on PAR. |
| What is the stock symbol of Klea? | Klea trades under ALKLH ticker. |
| When did Klea go public? | Klea went public in 2011. |
| Who are competitors of Klea? | Similar companies to Klea include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
| What is the current market cap of Klea? | Klea's current market cap is $59.7M |
| What is the current revenue of Klea? | Klea's last 12 months revenue is $21.2M. |
| What is the current revenue growth of Klea? | Klea revenue growth (NTM/LTM) is 19%. |
| What is the current EV/Revenue multiple of Klea? | Current revenue multiple of Klea is 2.9x. |
| Is Klea profitable? | Yes, Klea is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Klea? | Klea's last 12 months EBITDA is $4.5M. |
| What is Klea's EBITDA margin? | Klea's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Klea? | Current EBITDA multiple of Klea is 13.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
